Objectives
- Discuss how clinical research networks can be leveraged for public health emergency/pandemic preparedness and response.
- Prepare clinical research networks for international collaboration during future preparedness and response efforts based on recent lessons learned from COVID-19 and other infectious disease outbreaks.
- Expand existing and create new collaborative research networking opportunities.
For each of the below presentations, click on the language of your preference: English (Eng), Spanish (Spa), French (Fre), Bahasa (Bah).
Welcoming Remarks and Introduction
Keynote Remarks
Dr. Hugo López-Gatell – Mexico Undersecretary of Health.
Dr. William Lee Alardin – Coordinator of Scientific Research, National Autonomous University of Mexico in representation of Dr. Enrique Graue Wiechers, Rector.
Dr. Anthony Fauci (video message) – Director, National Institute of Allergy, and Infectious Diseases.
Session I – Rapid Response Approaches
Epidemiology of Infectious Diseases in Mexico and Evolution of LaRed
Session II – Policy in a Rapid Response Environment
Policy and Considerations for Rapid Clinical Research during Pandemic Responses
Session III – Diagnostics Development and Facing Multiple Outbreaks Simultaneously
Diagnostic Testing Developments – Pathogens, Discovery, and New Technologies
Session IV: Vaccine Development
Evolution and dynamics of SARS-CoV-2 variants in Mexico
Session V – Therapeutic & Observational Study Designs and Key Aspects of Regional Collaborations
Master Adaptive Protocol Design – ACTT
Global Observational Studies Development and Implementation